Jeff Scott Kimball

Jeff Kimball practices at Corona Orthopaedic Associates Medical Group Inc in Corona, California.

Jeff Kimball's NPI, 1750814182, was assigned on April 3, 2017. Jeff Kimball graduated from Drexel University College Of Medicine in 2017. Jeff Kimball holds California license A157125.

Jeff Kimball's primary practice is Corona Orthopaedic Associates Medical Group Inc, at 341 Magnolia Ave, Corona, CA 92879 in Riverside County. The practice phone is (951) 735-6060.

Jeff Kimball's primary practice is Corona Orthopaedic Associates Medical Group Inc in Corona, California. Jeff Kimball is also affiliated with Corona Regional Medical Center. The medical group on file is Corona, Temecula Orthopaedic Associates Medical Group. Dmand AI also links Jeff Kimball to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jeff Kimball practices, 3 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Jeff Kimball's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dmand AI has Jeff Kimball's licenses on file in 2 states: California and Utah.

Dmand AI lists arm, wrist, hand fracture and dislocation, arthritis, joint pain, knee injury, leg, ankle or foot fracture and shoulder arthroscopy/rotator cuff repair among the conditions Jeff Kimball treats.

CMS data shows 1,247 Medicare services from Jeff Kimball across 9 procedure codes in 2024, for 244 Medicare patients. Medicare paid $43,924 for them. Every service was in an office.

CMS counts 244 Medicare patients who saw Jeff Kimball in 2024. The largest group is 65 to 74, with 130 patients. 75% of them have arthritis, and 75% have high blood pressure. 35% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Jeff Kimball's median patient age at 58, with 56% women.

In 2024, Jeff Kimball wrote 565 Medicare Part D claims for 249 patients. 98% of them were for generic drugs. CMS names the drug for 521 of them, across 9 drugs with 11 or more claims each, at $2,060 in total drug cost. In 2023, CMS named 64 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 78 out of 100 for Jeff Kimball for performance year 2024, reported as part of a group. Jeff Kimball accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 38 procedures of upper limb (arm) arthroscopy (minimally invasive joint repair) by Jeff Kimball, more than 80% of the clinicians it reports for that procedure.

Knee replacement: 1 to 10 procedures (CMS shows small counts as a range)

Lower limb (leg) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 12 papers to Jeff Kimball, published from 2012 to 2024. 2012 was the busiest year, with 2. The most frequent topics are Scoliosis, Lumbar Vertebrae and Spinal Fusion. Jeff Kimball has published most often in J Neurosurg Spine. Jeff Kimball's most frequent co-authors are Amer Samdani, MD, Steven Wei-Hung Hwang, MD and Joshua Matthew Pahys, MD.

CMS Open Payments shows 40 general payments to Jeff Kimball from 8 drug and device companies from 2022 to 2025. Grants make up the largest share, 51% of the total. Arthrex, Inc. paid the most, $11,755.

Jeff Kimball graduated from Drexel University College Of Medicine in 2017.

Jeff Kimball is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.